The Europe butterfly needles market is expected to grow from US$ 47.23 million in 2022 to US$ 74.62 million by 2028. It is estimated to register a CAGR of 7.9% from 2022 to 2028.

Rise in Prevalence of Chronic Diseases Drives Europe Butterfly Needles Market Growth

Butterfly needles used for drawing blood or administering medications in veins. Patients who have difficulty to venipuncture are often given butterfly needles. A butterfly needle is also known as a winged infusion set or a scalp vein set, as it has plastic wings on either side of the hollow needle. With their winged tubing structure, which allows greater flexibility, butterfly needles are easy to use and less painful. Additionally, butterfly needles are commonly used to draw blood or administer medication for babies, young children, and elder people. According to the latest data from the World Health Organization, cardiovascular diseases account for most noncommunicable disease-related deaths, followed by cancers, chronic respiratory diseases, and diabetes. Cancer can be identified by tumor marker tests that use a blood sample to look for chemicals made by cancer cells. Butterfly needles are used to draw blood along with medication administration among cancer patients. Furthermore, a butterfly needle is used for drawing blood for cholesterol testing. High cholesterol can cause heart attack and stroke. Further, diabetes is another life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. Often, insulin is administered through butterfly needles, as they are smaller and thinner than an intravenous (IV) catheter and have smaller gauge sizes, ranging from 18 to 27 gauge on average. Thus, the growing prevalence of chronic diseases requiring blood draws, long-term medications, and drug infusions is boosting the growth of the Europe butterfly needles market .

Europe Butterfly Needles Market Overview

The Europe butterfly needles market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the market in 2022. Germany has a well-developed healthcare system, and all the legal & German residents are entitled for free necessary medical help, and it is funded by statutory contribution system. It is mandatory for all the residents to have medical insurance that covers outpatient, inpatient, medical health, and prescription drug. The growth of the butterfly needles market in Germany is prominently attributed to the increasing prevalence of chronic disorders such as cancer, cardiovascular disorders, and neurological conditions that has increased number of hospitalizations in the country. According to the latest WHO data published in 2020, coronary heart disease deaths reached 147,055 or 20.98% of total deaths in Germany. Additionally, rising R&D activities and increasing technological innovations are likely to boost the butterfly needles market during the forecast period. Becton Dickinson Benelux N.V., launched BD Vacutainer UltraTouch Push Button Blood Collection Set with Pre-Attached Holder. A pre-attached holder prevents accidental needlestick injury due to the non-patient (tube-side) needle and help ensure compliance with OSHA’s single-use holder requirement. Thus, above discussed factors are expected to drive the growth of the butterfly needles market during the forecast period.

Europe Butterfly Needles Market Revenue and Forecast to 2028 (US$ Million)

Europe Butterfly Needles Market Segmentation

The Europe butterfly needles market is segmented based on application, end user, and country.

Based on application, the Europe butterfly needles market is segmented into blood collection, IV rehydration, delivery of medications, venipuncture, and blood transfusion. The blood collection segment held the largest Europe butterfly needles market share in 2022.

Based on end user, the Europe butterfly needles market is segmented into hospitals, clinics, blood banks, and others. The hospitals segment held the largest Europe butterfly needles market share in 2022.

Based on country, the Europe butterfly needles market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany dominated the Europe butterfly needles market in 2022.

B. Braun SE, Becton Dickinson and Co, Cardinal Health Inc, ICU Medical Inc, Medline Industries Inc, Nipro Corp, SB-Kawasumi Laboratories Inc, Terumo Corp, and Vogt Medical Vertrieb GmbH are the leading companies operating in the Europe butterfly needles market.